Dyadic (DYAI) Highlights.
"In just over a year and a half we have entered into over 15 proof of concept collaborations for both human and animal health...
Adding Citius (CTXR) $0.55 to Watch List.
Best Presentation at Dawson James Conference.
We attended the Dawson James Conference on October 29th, which had over 20 medtech and biotech companies. The two...
Dyadic (DYAI) $7.00 Called a ‘Gamechanger’ – Gets $14 Price Target.
Highly Respected Wall Street Analyst Jason Kolbert Issues $14.00 Price Target On Dyadic.
Analyst Take: "Potential to be Revolutionary. Dyadic’s C1 shows potential in...
Investor Presentation Slides From Dyadic (DYA) $6.40.
Really, How Do We Do It?
Live Short Term Chart
INVESTOR PRESENTATION
LONGER TERM CHART
Client, see published reports for disclosure and disclaimer details.
Citius Pharma’s (CTXR) Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris.
CRANFORD, N.J., May 13, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, provided...
Latest article
$269 Million in Cash. $178 Million Market Cap. What are the Odds? Adding to...
Here's the balance sheet.. Imagine being the CEO?
Wife: "Honey, I'm going to the mall, do we have money in the checking?" CEO "Yes, but...
Former CIA Deputy Director and Chief Technology Officer Joins Sekur Private Data (SWISF).
Strategic Advisory Board Member John T. Lewis, Role Expanded to Chief Technology Officer At Sekur Private Data.
The press release link below list nearly all of...
Three Stocks Percolating, Up 106%, Up 169%, and up 483%.
Odyssey Marine (OMEX) gained 169%, on a 259 million share day, from where we added it to 2026 Watch list. Society Pass (SOPA) gained...
